Prospective multicenter study of a synthetic bioabsorbable anal fistula plug to treat cryptoglandular transsphincteric anal fistulas

Dis Colon Rectum. 2015 Mar;58(3):344-51. doi: 10.1097/DCR.0000000000000288.

Abstract

Background: Although interest in sphincter-sparing treatments for anal fistulas is increasing, few large prospective studies of these approaches have been conducted.

Objective: The study assessed outcomes after implantation of a synthetic bioabsorbable anal fistula plug.

Design: A prospective, multicenter investigation was performed.

Setting: The study was conducted at 11 colon and rectal centers.

Patients: Ninety-three patients (71 men; mean age, 47 years) with complex cryptoglandular transsphincteric anal fistulas were enrolled. Exclusion criteria included Crohn's disease, an active infection, a multitract fistula, and an immunocompromised status.

Intervention: Draining setons were used at the surgeon's discretion. Patients had follow-up evaluations at 1, 3, 6, and 12 months postoperatively.

Main outcome measures: The primary end point was healing of the fistula, defined as drainage cessation plus closure of the external opening, at 6 and 12 months. Secondary end points were fecal continence, duration of drainage from the fistula, pain, and adverse events during follow-up.

Results: Thirteen patients were lost to follow-up and 21 were withdrawn, primarily to undergo an alternative treatment. The fistula healing rates at 6 and 12 months were 41% (95% CI, 30%-52%; total n = 74) and 49% (95% CI, 38%-61%; total n = 73). Half the patients in whom a previous treatment failed had healing. By 6 months, the mean Wexner score had improved significantly (p = 0.0003). By 12 months, 93% of patients had no or minimal pain. Adverse events included 11 infections/abscesses, 2 new fistulas, and 8 total and 5 partial plug extrusions. The fistula healed in 3 patients with a partial extrusion.

Limitations: The study was nonrandomized and had relatively high rates of loss to follow-up.

Conclusion: Implantation of a synthetic bioabsorbable fistula plug is a reasonably efficacious treatment for complex transsphincteric anal fistulas, especially given the simplicity and low morbidity of the procedure.

Trial registration: ClinicalTrials.gov NCT01290666.

Publication types

  • Clinical Trial
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Abdominal Wound Closure Techniques*
  • Absorbable Implants*
  • Digestive System Surgical Procedures / methods*
  • Dioxanes / therapeutic use
  • Drainage* / adverse effects
  • Drainage* / instrumentation
  • Drainage* / methods
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Polyglycolic Acid / therapeutic use
  • Postoperative Complications* / classification
  • Postoperative Complications* / epidemiology
  • Rectal Fistula / physiopathology
  • Rectal Fistula / surgery*
  • Surgical Instruments*
  • Treatment Outcome
  • United States
  • Wound Healing

Substances

  • Dioxanes
  • Polyglycolic Acid
  • trimethylene carbonate

Associated data

  • ClinicalTrials.gov/NCT01290666